Table 2.
Liver parenchyma | ER AP (%) | ER PVP (%) | ER LVP (%) | |
---|---|---|---|---|
D | r | 0.206 | 0.107 | 0.232 |
p | 0.067 | 0.34 | 0.039 | |
D* | r | 0.146 | 0.310 | 0.314 |
p | 0.19 | 0.005 | 0.004 | |
PF | r | −0.07 | −0.009 | −0.018 |
p | 0.53 | 0.93 | 0.87 | |
ADC | r | 0.172 | 0.001 | 0.167 |
p | 0.12 | 0.98 | 0.13 |
HCC | ER AP | ER PVP | ER LVP | |
---|---|---|---|---|
D | r | −0.288 | −0.357 | −0.344 |
p | 0.009 | 0.001 | 0.001 | |
D* | r | 0.078 | 0.044 | −0.005 |
p | 0.493 | 0.695 | 0.962 | |
PF | r | 0.364 | 0.309 | 0.281 |
p | <0.001 | 0.005 | 0.011 | |
ADC | r | −0.084 | −0.167 | −0.172 |
p | 0.45 | 0.139 | 0.128 |
D, true diffusion coefficient (×10−3 mm2/s), D*, pseudodiffusion coefficient (×10−3 mm2/s), PF, perfusion fraction (%), ADC, apparent diffusion coefficient, ER, enhancement ratio (%), AP, arterial phase, PVP, portal venous phase, LVP, late venous phase.
Significant p-values are bolded.